ASX Share rice
Thu 06 Aug 2020 - 03:10:am (Sydney)

RAP Share Price

RESAPP HEALTH LIMITEDRAPHealth Care Equipment & Services

RAP Company Information

Name:

ResApp Health Limited

Sector:

Healthcare

Industry:

Health Information Services

GIC Industry:

Health Care Technology

GIC Sub Industry:

Health Care Technology

Address:

100 Creek Street Brisbane QLD Australia 4000

Phone:

61 7 3724 0035

CEO, MD & Director:

Dr. Anthony Keating

VP of Technology:

Rob Keniger

Scientific Founder & Consultant:

Dr. Udantha Abeyratne Ph.D.

Company Sec.:

Ms. Nicki Farley

Founder and Director of R&D of Cavidi AB:

Dr. Clas Källander

Company Overview:

ResApp Health Limited develops digital healthcare solutions to assist doctors and allow patients to diagnose and manage respiratory disease. The company delivers mobile software apps in various clinical settings, including telehealth, emergency, urgent care, and primary care. Its technology uses sound to diagnose respiratory diseases, including pneumonia, bronchiolitis, bronchitis, chronic obstructive pulmonary disease, and asthma. The company was formerly known as Narhex Life Sciences Limited. ResApp Health Limited was founded in 2014 and is headquartered in Brisbane, Australia.

RAP Share Price Information

Shares Issued:

726.03M

Market Capitalisation:

$108.90M

Revenue (TTM):

$59.22K

Earnings per Share:

$-0.008

Operating Margin (TTM):

$-101.56

Return On Assets (TTM):

$-0.44

Return On Equity (TTM):

$-0.84

Quarterly Revenue Growth (YOY):

-0.4

Diluted Earnings Per Share (TTM):

$-0.009

RAP CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$-36,131

Change To Liabilities:

$698.62K

Total Cashflow From Investing Activities:

$-36,131

Net Income:

$-5,439,459

Total Cash From Operating Activities:

$-4,851,308

Depreciation:

$140.20K

Change To Account Receivables:

$-924,217

Sale Purchase Of Stock:

$-494,074

Capital Expenditures:

$36.13K

RAP Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-5,439,459

Net Income:

$-5,439,459

Gross Profit:

$2.83M

Operating Income:

$-8,265,946

Other Operating Expenses:

$-2,732,370

Total Revenue:

$2.83M

Total Operating Expenses:

$8.27M

RAP Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$1.89M

Total Liabilities:

$1.72M

Total Stockholder Equity:

$7.69M

Other Current Liabilities:

$172.40K

Total Assets:

$9.41M

Common Stock:

$28.78M

Retained Earnings:

$-27,871,571

Other Liabilities:

$39.74K

Cash:

$5.52M

Total Current Liabilities:

$1.68M

Property - Plant & Equipment:

$30.85K

Net Tangible Assets:

$5.80M

Total Current Assets:

$7.49M

Net Receivables:

$1.90M

Short-Term Investments:

$1.92M

Accounts Payable:

$591.87K

Non Currrent Assets (Other):

$1.92M

Short-Term Investments:

$1.92

Non Current Liabilities Total:

$39.74K

RAP Share Price History

RAP News

22 Jul, 2020
ResApp Health Limited's (ASX:RAP): ResApp Health Limited develops digital healthcare solutions to assist doctors and...
16 Jan, 2020
ResApp Health Limited's (ASX:RAP): ResApp Health Limited develops digital healthcare solutions to assist doctors and...
20 Nov, 2019
We can readily understand why investors are attracted to unprofitable companies. For example, ResApp Health (ASX:RAP...
14 Oct, 2019
If you're interested in ResApp Health Limited (ASX:RAP), then you might want to consider its beta (a measure of share...